Welcome
Support Centre
17 May 2012 
ISRCTN Register - International Standard Randomized Controlled Trial Number
Trial registration
Unique identification scheme
International databases
home  |   my details  |   ISRCTN Register  |   mRCT  |   links  |   information  |   press
Find trials
ISRCTN Register
tips on searching

Registration
New application
Updating record

Information
introduction
governing board
ISRCTN FAQs
data set
letter of agreement
request information
guidance notes

[ ...Back to search results ] [ Print-friendly version ]
Norfolk Platelet And Stroke Study (PASS)
ISRCTN ISRCTN09053426
ClinicalTrials.gov identifier
Public title Norfolk Platelet And Stroke Study (PASS)
Scientific title Investigation of the clinical utility of platelet function testing following stroke and transient ischaemic attack: a non-randomised observational clinical laboratory study
Acronym PASS
Serial number at source 9199
Study hypothesis Platelet aggregation or stickiness is a fundamental part of having a stroke or transient ischaemic attack (TIA). Most patients following a stroke take anti-platelet drugs (e.g. aspirin) to specifically deal with this aspect of the illness and aspirin and drugs like it have provided significant clinical benefit in terms of reducing further strokes for this patient group. Despite this anti-platelet drug treatment a number of patients go on to have further strokes (and heart attacks). We and others believe that resistance to the drugs accounts for a significant number of aspirin or anti-platelet drug failure and this may affect between 5-35% of patients. As yet we have no routinely clinically useful way of effectively and reliably assessing the effect of the antiplatelet drugs in stroke patients.

Our principal objective is to investigate the clinical utility of platelet function analysis in predicting outcomes following stroke and transient ischaemic attacks (TIA). We will be using a new generation of platelet function analysers about the size of a home computer which if found to be useful could be used in any hospital or clinic.

The study requires from the patient a blood test (one 4 ml blood tube per test on one or two occasions) where possible at the time of normal blood testing. As this automated technology for platelet function testing is new it first needs to be evaluated in our hands as follows:

1. Determine the normal reference range and imprecision of the multiplate (platelet function analyser) instrument in the NNUH laboratory in 20 healthy volunteers who do not take anti platelet therapy and compare to published data
2. Determine the imprecision of the multiplate instrument in acute stroke patients who are receiving antiplatelet therapy
3. Establish the optimal time for testing platelet function in acute stroke patients following commencement of aspirin therapy
4. Establish the reproducibility of the multiplate test in normal
Lay summary Not provided at time of registration
Ethics approval MREC (ref: 09/H0310/92)
Study design Single centre non-randomised observational clinical laboratory study
Countries of recruitment United Kingdom
Disease/condition/study domain Stroke
Participants - inclusion criteria 1. Over the age of 18 years old (we are a department that treats adult patients)
2. Patient admitted under the care of the department of medicine with a stroke/transient ischaemic attack (TIA) at the Norfolk and Norwich Hospital
3. Within 72 hours of admission with a stroke/TIA
4. Must have received 1 dose of at least 75 mg of aspirin orally before testing
Participants - exclusion criteria 1. Unfit for procedure (phlebotomy)
2. Patients not given aspirin
Anticipated start date 01/02/2010
Anticipated end date 31/03/2011
Status of trial Completed
Patient information material Not available in web format, please use the contact details below to request a patient information sheet
Target number of participants Planned sample size: 80
Interventions 1. The observations consist of a blood test to assess platelet function following stroke/TIA
2. Follow-up length: 12 months
Primary outcome measure(s) Platelet function result at time of stroke/TIA
Secondary outcome measure(s) Measured at at 90 days and 1 year:
1. Re-stroke
2. Other vascular event
3. Death
Sources of funding British Society for Haematology (BSH) (UK)
Trial website
Publications
Contact name Dr  Kris  Bowles
  Address Colney Lane
Colney
  City/town Norwich
  Zip/Postcode NR4 7UY
  Country United Kingdom
  Email KRISTIAN.BOWLES@nnuh.nhs.uk
Sponsor Norfolk and Norwich University Hospital NHS Foundation Trust (UK)
  Address Colney Lane
Colney
  City/town Norwich
  Zip/Postcode NR4 7UY
  Country United Kingdom
  Sponsor website: http://www.nnuh.nhs.uk/
Date applied 11/02/2011
Last edited 18/07/2011
Date ISRCTN assigned 18/07/2011
Submit your trial protocol
Submit to Trials journal
Follow us on Twitter
© 2012 ISRCTN unless otherwise stated.


BioMed Central